Journal
CHEMICO-BIOLOGICAL INTERACTIONS
Volume 186, Issue 1, Pages 16-23Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2010.03.042
Keywords
AA3E2; Anti-amyloidogenic; A beta(1-42) fibril; Alzheimer's disease; Docking
Funding
- Research Council of University of Tehran
Ask authors/readers for more resources
beta-Amyloid peptide (A beta) is believed to play a recognized role in pathogenesis of Alzheimer's disease (AD). Self-association of A beta peptide into amyloid fibrils causes neurotoxicity. Compounds capable of interfering with A beta-A beta interaction through binding to nucleation sites can inhibit A beta amyloidogenesis and A beta-induced cytotoxicity. AA3E2 is a triazine-derivative whose anti-amyloidogenic ability has previously been established. In the present study, we evaluated the protective effect of AA3E3 against A beta(1-42)-induced toxicity in SK-N-MC cell line. The cell exposure to the co-incubated A beta(1-42) with AA3E2 decreased the cell viability loss dose-dependently, compared to cells exposed to A beta(1-42) fibrils. Co-incubation with AA3E2 also attenuated the ROS production, activation of caspase-3 and the extent of apoptotic cell death induced by A beta(1-42) fibril. Moreover, the 3D structure of the molecular associates between A beta(1-42) and AA3E2 were theoretically determined by docking studies. Our docking data indicated that AA3E2 inhibits the formation of AS fibril likely via binding to the nucleation site within the hydrophobic region of A beta (KLVFF). These observations provide the background for future design of more elegant beta-breaking agents for dissolution of A beta fibrillar aggregates. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available